Clinical Trial Update: Omega 3 for Treatment of Depression in Patients With Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial results for omega-3 fatty acids in treating depression among patients with heart failure have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Wei Jiang | Conditions: Depression | Phase 3 | Status: COMPLETED | Results posted: 2017-06-12